Survival outcomes in glioma patients with noncanonical IDH mutations: Beyond diagnostic improvements.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.15_suppl.2028
Abstract: 2028 Background: According to the 2016 WHO classification of Central Nervous System tumors, the assessment of exon 4 mutations in IDH1 or IDH2 genes is an essential step in the characterization of gliomas. The R132H… read more here.
Keywords: canonical mutations; canonical idh1; non canonical; idh mutations ... See more keywords